All tenders
75F40122C00154
DESIGN A TWO-STAGE PROCESS FOR USING RWE TO SUPPORT LABELING EXPANSIONS FOR EFFECTIVENESS CLAIMS THAT IS ALIGNED WITH REGULATORY REQUIREMENTS/DEMONSTRATE AND EMPIRICALLY TEST THE PROCESS WITH HISTORICAL AND ONGOING RCTS FOR SUPPLEMENTAL INDICATIONS/
Food and Drug Administration · United States
This contract has been awarded. Browse open opportunities
Time Left to Bid
Awarded
AwardedHealthcare & MedicalFederal
Basic information
- Reference number
- 75F40122C00154
- Issuing organization
- Food and Drug Administration · Find award history →
- Government level
- Federal
- Solicitation type
- Healthcare & Medical
- Title
- DESIGN A TWO-STAGE PROCESS FOR USING RWE TO SUPPORT LABELING EXPANSIONS FOR EFFECTIVENESS CLAIMS THAT IS ALIGNED WITH REGULATORY REQUIREMENTS/DEMONSTRATE AND EMPIRICALLY TEST THE PROCESS WITH HISTORICAL AND ONGOING RCTS FOR SUPPLEMENTAL INDICATIONS/
- Source
- USASpending (Federal)
- Source ID
- usa-75F40122C00154
Details
- Location
- United States
Description
DESIGN A TWO-STAGE PROCESS FOR USING RWE TO SUPPORT LABELING EXPANSIONS FOR EFFECTIVENESS CLAIMS THAT IS ALIGNED WITH REGULATORY REQUIREMENTS/DEMONSTRATE AND EMPIRICALLY TEST THE PROCESS WITH HISTORICAL AND ONGOING RCTS FOR SUPPLEMENTAL INDICATIONS/ Awarded to: BRIGHAM & WOMENS HOSPITAL INC Agency: Department of Health and Human Services Sub-agency: Food and Drug Administration Award type: DEFINITIVE CONTRACT
Dates
- Publication
- 2022/09/27 12:00:00 AM UTC
- Closing date
- 2027/06/27 12:00:00 AM UTC
Estimated value
$2.7M USD
Classification
Normalized category
Healthcare & Medical